Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties
about
Vaginal drug distribution modelingRelationships between perceptual attributes and rheology in over-the-counter vaginal products: a potential tool for microbicide developmentThe Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product DevelopmentVaginal deployment and tenofovir delivery by microbicide gels"Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gelsLearning from the private sector: towards a keener understanding of the end-user for microbicide introduction planning.Firmness Perception Influences Women's Preferences for Vaginal Suppositories.User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings.Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment.User input in iterative design for prevention product development: leveraging interdisciplinary methods to optimize effectiveness.A Comparative Pre-Phase I Study of the Impact of Gel Vehicle Volume on Distal Colon Distribution, User Experience, and Acceptability.Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design.Women and ARV-based prevention: opportunities and challenges.Vaginal film for prevention of HIV: using visual and tactile evaluations among potential users to inform product design.User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences.
P2860
Q28088306-C0F01B5F-B31F-45F2-8604-F4B05F855AB1Q28542817-0346C7B2-7FEE-4195-8D9E-E620C13F8D90Q28551783-E59BAEEB-603E-4A49-BF7F-2464A478A504Q30647900-F8E32EEC-B15F-4F01-B844-B2E40842441BQ33601303-AFE886B1-E839-4DDC-A29D-8B9951727B40Q34180594-4C9B72F6-8F77-422C-9CC5-02C4903AC4D1Q34309847-A1DCF80A-C3E6-4B4F-AC6C-484B90DC515BQ35082722-4DC42C06-392D-468D-A5FF-66C2F60446B1Q36331527-459C55F1-FB4F-4041-AD24-1979D58D1F0AQ36934918-A34DA11E-A4D4-474E-9A64-36B635AAB1D9Q40156813-EBA7D6C2-E3E2-49C2-944F-C3B873B0C336Q40460028-D7F83AAB-8A7D-4183-BFD0-D6239EB1CB2FQ41640436-51142C67-E0DF-409F-BDBD-4640794B1A9BQ42668432-37713E59-C5A8-43F3-8EC6-BA59B98EA5B3Q46553256-E2974F1C-D31E-44A8-9E22-84B386464C69Q47834269-F8C9A1F6-8C54-489F-98DB-9234F4F2EDC9Q54943162-B13EF0F1-D25D-4F38-BE72-0E1611F780C7
P2860
Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Designing preclinical percepti ...... nces to formulation properties
@en
Designing preclinical percepti ...... ces to formulation properties.
@nl
type
label
Designing preclinical percepti ...... nces to formulation properties
@en
Designing preclinical percepti ...... ces to formulation properties.
@nl
prefLabel
Designing preclinical percepti ...... nces to formulation properties
@en
Designing preclinical percepti ...... ces to formulation properties.
@nl
P2093
P2860
P356
P1476
Designing preclinical percepti ...... nces to formulation properties
@en
P2093
David F Katz
David R Friend
E Milu Kojic
Joseph L Fava
Julia G Shaw
Kathleen M Morrow
Project Link Study Team
Rochelle K Rosen
Sara Vargas
P2860
P356
10.1089/AID.2013.0099
P577
2013-12-09T00:00:00Z